Author

Y. Rybakova

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Approach:machine learning (classical)· 1

Frequent Co-Authors

A. Gardner· 1 shared A. Lopes· 1 shared A. Lytoon-Jean· 1 shared A. M. Hayward· 1 shared A. R. Kirtane· 1 shared C. K. Soule· 1 shared C. Whittaker· 1 shared D. Anderson· 1 shared

Activity by Year

2019-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

A. Gardner

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Identification of a long non-coding RNA regulator of liver carcinoma cell survival

Y. Rybakova, J. Gonzalez, R. Bogorad, V. Chauhan, Y. Dong, C. Whittaker, V. Koteliansky, D. Anderson

The paper identifies a long non-coding RNA, ASTILCS, critical for HCC cell survival and overexpressed in patient tumors.

bioRxiv · Jul 1, 2020Cancer Biology

Computationally guided high-throughput design of self-assembling drug nanoparticles

D. Reker, Y. Rybakova, A. R. Kirtane, R. Cao, J. W. Yang, N. Navamajiti, A. Gardner, R. M. Zhang, T. Esfandiary, J. L'Heureux, T. von Erlach, E. M. Smekalova, D. Leboeuf, K. Hess, A. Lopes, , G. Traverso

This paper develops a high-throughput screening platform with machine learning to design self-assembling drug nanoparticles, identifying 101 novel formulations from 2.1 million combinations.

bioRxiv · Sep 30, 2019Bioengineering